Become a Product Manager at BenevolentAI London

BenevolentAI, founded in 2013, creates and applies AI technologies to transform the way medicines are discovered and developed. BenevolentAI seeks to improve patients' lives by applying technology designed to generate better data decision making and in doing so decrease drug discovery failure rates, lower drug development costs and increase the speed at which medicines are generated. The company has developed the Benevolent Platform - a discovery platform used by BenevolentAI scientists to find new ways to treat disease and personalise drugs for patients. BenevolentAI is HQ'd in London with a research facility in Cambridge (UK) and further offices in New York and Antwerp. BenevolentAI has active R&D drug programmes from discovery to Phase IIb in disease areas such as ALS, Atopic dermatitis, Ulcerative Colitis and Sarcopenia.